Neurologic outcomes and mortality (ruptured aneurysms)
| mRS | Frequency (No. of Patients)a | Description (No.) |
|---|---|---|
| 0 | 8 | |
| 2 | 3 | Residual deficit after SAH (2), stroke due to stent occlusion after stopping antiplatelet therapy for shunt placement 2 months after procedure (1) |
| 3 | 1 | Symptomatic intracranial hemorrhage following shunt revision while on antiplatelet therapy (1) |
| 6 | 5 | Aneurysm rebleeding (2), complications of SAH/vasospasm (3) |
↵a One patient lost to follow-up.